Argenica Therapeutics Doses First Batch of Patients for Phase Two Stroke Trial
Argenica Therapeutics Doses First Batch of Patients for Phase Two Stroke Trial
Argenica Therapeutics 为第二阶段中风试验的第一批患者服药
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册